Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001411920-12-000003
Filing Date
2012-05-30
Accepted
2012-05-30 14:03:45
Documents
1
Effectiveness Date
2012-05-30
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9117
  Complete submission text file 0001411920-12-000003.txt   10257
Mailing Address 140 W 57th St SUITE 9C New York NY 10019
Business Address 140 W 57th St SUITE 9C New York NY 10019 212-582-1199
IRX Therapeutics, Inc. (Filer) CIK: 0001411920 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-178994 | Film No.: 12876944